Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BLK | Nasser Amin H. | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLK | Murphy Kathleen | Director | 30.09.2026 | Zuteilung | — | 36 | — | Form 4 |
| BLK | Lemkau Gregg | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLK | Johnson Margaret L | Director | 30.09.2026 | Zuteilung | — | 33 | — | Form 4 |
| BLK | Ford William E | Director | 30.09.2026 | Zuteilung | — | 34 | — | Form 4 |
| BLK | Daley Pamela | Director | 30.09.2026 | Zuteilung | — | 27 | — | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 28.09.2026 | Verkauf | 1,10 | 22.523 | 24.820 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 2.666 | 321.626 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 8.333 | 1.005.293 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Optionsausübung | 2,80 | 8.333 | 23.332 | Form 4 |
| BLTE | Chen Wan-Shan | Director | 24.09.2026 | Optionsausübung | 0,4386 | 13.796 | 6.051 | Form 4 |
| BLSH | Bliss Andrew | Director | 24.09.2026 | Verkauf | 40,10 | 100 | 4.010 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Verkauf | 125,00 | 3.333 | 416.625 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Optionsausübung | 2,80 | 3.333 | 9.332 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 24.09.2026 | Verkauf | 120,00 | 1.416 | 169.920 | Form 4 |
| BLSH | Bliss Andrew | Director | 23.09.2026 | Verkauf | 40,22 | 59.976 | 2.412.031 | Form 4 |
| BLSH | Bliss Andrew | Director | 22.09.2026 | Verkauf | 40,79 | 108.200 | 4.413.056 | Form 4 |
| BLSH | Bliss Andrew | Director | 21.09.2026 | Verkauf | 40,20 | 76.953 | 3.093.888 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 21.09.2026 | Verkauf | 1,19 | 21.009 | 25.022 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 21.09.2026 | Verkauf | 106,61 | 1.416 | 150.960 | Form 4 |
| BLFS | Berard Todd | Chief Marketing Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 470 | 17.244 | Form 4 |
| BLFS | Mathew Aby J. | EVP & Chief Scientific Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 564 | 20.693 | Form 4 |
| BLFS | Werner Sean | Chief Technology Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 421 | 15.446 | Form 4 |
| BLFS | De Greef Roderick | President and CEO | 18.09.2026 | Steuer-Abgabe | 36,69 | 2.775 | 101.815 | Form 4 |
| BLFS | Wichterman Troy | Chief Financial Officer | 18.09.2026 | Steuer-Abgabe | 36,69 | 937 | 34.379 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,29 | 5.840 | 644.112 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,31 | 2.920 | 322.100 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,30 | 6.968 | 768.561 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,36 | 19.384 | 2.139.193 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 30,78 | 5.840 | 179.755 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 17,12 | 2.920 | 49.990 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 11,55 | 6.968 | 80.480 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Optionsausübung | 8,65 | 19.384 | 167.672 | Form 4 |
| BLBD | Sanfrey Jeffrey Scott | Chief Operating Officer | 16.09.2026 | Verkauf | 62,40 | 4.000 | 249.600 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 14.09.2026 | Verkauf | 1,43 | 17.731 | 25.267 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,00 | 2.666 | 261.268 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 101,49 | 3.143 | 318.989 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 100,78 | 2.010 | 202.559 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 99,57 | 1.500 | 149.352 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,64 | 1.680 | 165.708 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 101,44 | 7.214 | 731.793 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 100,58 | 2.531 | 254.570 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 99,57 | 2.456 | 244.547 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,63 | 4.465 | 440.389 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Optionsausübung | 2,80 | 8.333 | 23.332 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Optionsausübung | 2,80 | 16.666 | 46.665 | Form 4 |
| BLND | Venkatramani Srinivasan | Head of Product Tech & Cust Op | 11.09.2026 | Verkauf | 1,43 | 74.705 | 106.828 | Form 4 |
| BLDR | Steinke Craig Arthur | Director | 10.09.2026 | Zuteilung | — | 564 | — | Form 4 |
| BLDR | Charles Dirkson R | Director | 10.09.2026 | Zuteilung | — | 470 | — | Form 4 |
| BLDR | Oleary James | Director | 10.09.2026 | Zuteilung | — | 564 | — | Form 4 |
| BLDR | Renz Maria | Director | 10.09.2026 | Zuteilung | — | 489 | — | Form 4 |
| BLDR | Levy Paul S | Director | 10.09.2026 | Zuteilung | — | 1.204 | — | Form 4 |
| BLDR | Hayes William B | Director | 10.09.2026 | Zuteilung | — | 583 | — | Form 4 |
| BLDR | Christophe Cleveland A | Director | 10.09.2026 | Zuteilung | — | 564 | — | Form 4 |
| BLDR | Boydston Cory Jacobs | Director | 10.09.2026 | Zuteilung | — | 470 | — | Form 4 |
| BLLN | Sakakibara Shan Riku | Chief Product Officer | 10.09.2026 | Schenkung | — | 3.500 | — | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 09.09.2026 | Verkauf | 100,00 | 10.000 | 1.000.000 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 09.09.2026 | Optionsausübung | 2,80 | 10.000 | 28.000 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 09.09.2026 | Verkauf | 97,54 | 1.416 | 138.117 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09.09.2026 | Schenkung | — | 20.000 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).